Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Goodwill & Intangibles (2010 - 2026)

Insmed (INSM) posted Goodwill & Intangibles of $229.6 million for Q2 2026, down 0.9% on a QoQ basis from $231.7 million in Q1 2026, and up 68.69% year-over-year from $136.1 million in Q2 2025.

Analysis

Insmed (INSM) Goodwill & Intangibles (2010 - 2026) Analysis & Trends

Insmed has reported Goodwill & Intangibles for 17 years, with the latest figure at $229.6 million in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles rose 68.69% year-over-year to $229.6 million in Q2 2026; TTM through Jun 2026 was $229.6 million, a 68.69% increase from a year earlier, with the FY2025 full-year figure at $233.8 million, up 20.02% from the prior year.
  • Goodwill & Intangibles was $229.6 million for Q2 2026 at Insmed, down from $231.7 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $233.8 million in Q4 2025, with the low at $136.1 million in Q2 2023.
  • Average Goodwill & Intangibles over 5 years is $189.6 million, with a median of $201.7 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles soared 343.76% in 2022, then slumped 34.37% in 2023.
  • Over 5 years, Goodwill & Intangibles stood at $204.9 million in 2022, then retreated by 2.47% to $199.8 million in 2023, then decreased by 2.53% to $194.8 million in 2024, then advanced by 20.02% to $233.8 million in 2025, then slipped by 1.78% to $229.6 million in 2026.
  • The last three Goodwill & Intangibles figures came in at $229.6 million (Q2 2026), $231.7 million (Q1 2026), and $233.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 229.60 Mn
Mar 31, 2026 231.68 Mn
Dec 31, 2025 233.76 Mn
Sep 30, 2025 220.70 Mn
Jun 30, 2025 136.11 Mn
Mar 31, 2025 193.50 Mn
Dec 31, 2024 194.76 Mn
Sep 30, 2024 136.11 Mn
Jun 30, 2024 136.11 Mn
Mar 31, 2024 198.55 Mn
Dec 31, 2023 199.81 Mn
Sep 30, 2023 136.11 Mn
Jun 30, 2023 136.11 Mn
Mar 31, 2023 203.60 Mn
Dec 31, 2022 204.87 Mn
Sep 30, 2022 206.13 Mn
Jun 30, 2022 207.39 Mn
Mar 31, 2022 208.66 Mn
Dec 31, 2021 209.92 Mn
Sep 30, 2021 211.18 Mn